Oncology
Studies advance knowledge in oncology research
Published in Gene Therapy Weekly, September 29th, 2005
Study 1: Complementary therapies bolster TRAIL-mediated death in breast cancer cells.
"Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in cancer cells but not in normal cells. Despite this promising feature, TRAIL resistance observed in cancer cells seriously challenged the use of TRAIL as a death ligand in gene therapy," investigators in Turkey report.
"The current dispute concerns whether or not TRAIL receptor expression pattern is the primary determinant of TRAIL sensitivity in cancer cells. This...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-09-29)
More Articles from Gene Therapy Weekly
- Breast Cancer
Bystander effect of INGN 241 increases cancer-killing activity in breast cancer - Gene Research
VEGF-A gene deletion disrupts thymus blood vessel architecture - Gene Therapy
RCVD enhances myocardial plasmid expression - Gene Therapy
ZAP-70 immunodeficiency corrected by intrathymic gene transfer - Vaccine Delivery
Degradable copolymers developed as novel gene carriers - Acute Myeloid Leukemia
Acute-leukemia sign may signal need for different therapy - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
